Wedbush reiterated their outperform rating on shares of Oculis (NASDAQ:OCS – Free Report) in a report issued on Friday morning, Benzinga reports. They currently have a $29.00 price objective on the stock. Other equities research analysts have also issued research reports about the stock. Robert W. Baird upped their price objective on shares of Oculis […]
Oculis to Present at Upcoming November Investor Conferences streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Oculis to Present a Late-Breaking Abstract at the 23rd EURETINA Congress on Positive Phase 3 Stage 1 DIAMOND Trial Results for Diabetic Macular Edema streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.